Lipoxen acquires SymbioTec in a stock deal valued at $9.3M

SymbioTec GmbH

Germany / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Lipoxen plc

U.K. / Small-Cap Biopharma (<$1 billion)

$25.5m on 08/05/2011 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed